The US FDAs Withdrawal of the Breast Cancer Indication for Avastin (Bevacizumab). Saudi Pharm. J. 2012, 20, 381–385. [Google Scholar] [CrossRef] [PubMed] [Green Version] Emens, L.A.; Adams, S.; Barrios, C.H.; Diéras, V.; Iwata, H.; Loi, S.; Rugo, H.S.; Schneeweiss, ...